Professor of neuromuscular disorders at Erasmus MC, University Medical Center in Rotterdam, the Netherlands

Pieter van Doorn


Pieter A. van Doorn is professor of neuromuscular disorders at  Erasmus MC,  University Medical Center in Rotterdam, the Netherlands, where he heads the neuromuscular branch. Dr van Doorn received his MD at Erasmus University Rotterdam. He was trained in neurology and clinical neurophysiology at the University Hospital Rotterdam-Dijkzigt (now Erasmus MC). He started his research in immune-mediated polyneuropathies at the department of immunohematology at Leiden State University in the Netherlands. In 1990, he completed his thesis on ‘Intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy (CIDP)’ (cum laude).

Dr van Doorn’s main field of interest are neuromuscular disorders, especially the immune-mediated neuropathies Guillain-Barré syndrome (GBS) and CIDP; and Pompe disease, a metabolic muscle disease due to alpha-glucosidase deficiency. He is pursuing studies that examine the relationships between infections, immune reaction/antiganglioside antibodies, and the effect of IVIg treatment. He is involved in therapeutic and long-term follow-up studies, research on the working mechanims of intravenous immunoglobulin (IVIg) and the development of outcome measures and prognostic modelling in GBS, CIDP and Pompe disease. Dr van Doorn has initiated and conducted several randomized placebo controlled trials and surveys in GBS and CIDP. He is PI of the ongoing second-dose IVIg trial in GBS patients with a poor prognosis (SID-GBS) and the IVIg dose-finding study in CIDP (DRIP study). He is involved in MR imaging of respiratory muscle dysfunction in Pompe disease. He recently joined the ‘Rotterdam study’, a large ongoing population study in middle aged and elderly, were his research focusses on the epidemiology and risk factors of polyneuropathy.

Dr van Doorn chairs the Inflammatory Neuropathy Consortium (INC) and was a board member of the Peripheral Nerve Society (PNS). He is co-chair of the Erasmus MC ‘Center of lysosomal and metabolic diseases’ and board member of the ‘European Pompe Consortium’ (EPOC). He is member of the IGOS steering committee, medical advisory board of the GBS-CIDP Foundation International and Spierziekten Nederland. He is board member of the Janivo Foundation. He chaired the organisation of the PNS/INC meeting 2012 in Rotterdam. Dr van Doorn is board member of several journals and has published over 300 papers in peer reviewed journals, he is co-author of the recent book ‘Neuromuscular disease, a case-based approach’.